Glyceryl trinitrate-induced angiotensin-converting enzyme (ACE) inhibition in healthy volunteers is dependent on ACE genotype

Canadian Journal of Physiology and Pharmacology

Volumn 83, Issue 12, 2005, Pages 1117-1122

  Persson, Karin ^a   Säfholm, Annette C E ^a   Andersson, Rolf G G ^a   Ahlner, Johan ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Angiotensin; Blood pressure; Enzymes; Genes; Nitroglycerin

Indexed keywords

CYCLIC GMP; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; NITRIC OXIDE;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; DIZZINESS; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; VOLUNTEER;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CYCLIC GMP; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NITROGLYCERIN; PEPTIDYL-DIPEPTIDASE A; VASODILATOR AGENTS;

EID: 33645957957     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y05-118     Document Type: Article

References (32)

1. Aberg, G., and Ferrer, P. 1990. Effects of captopril on atherosclerosis in cynomolgus monkeys. J. Cardiovasc. Pharmacol. 15: S65-S72. PMID: 1694934.
2. Ackermann, A., Fernàndez-Alfonso, M.S., Sánchez de Rojas, R., Ortega, T., Paul, M., and Gonzalez, C. 1998. Modulation of angiotensin-converting enzyme by nitric oxide. Br. J. pharmacol. 124: 291-298. doi: 10.1038/sj.bjp.0701836. PMID: 9641545.
3. Ahlner, J., Andersson, R.G.G., Torfgård, K., and Axelsson, K.L. 1991. Organic nitrate esters: clinical use and mechanisms of action. pharmacol. Rev. 43: 351-423. PMID: 1956955.
4. Alvarez, R., Gonzalez, p., Batalla, A., Reguero, J.R., Iglesias-Cubero, G., Hevia, S., et al. 2001. Association between the NOS3 (-786 T/C) and the ACE (I/D) DNA genotypes and early coronary artery disease. Nitric Oxide, 5: 343-348. PMID: 11485372.
5. Axelsson, K.L., Bornfeldt, K.E., Norlander, B., and Wikberg, J.E.S. 1988. Attomole sensitive radioimmunoassay for cyclic GMP. Second Messengers phosphoproteins, 12: 145-154. PMID: 2854558.
6. Butler, R., Morris, A.D., Burchell, B., and Struthers, A.D. 1999. DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans. Hypertension, 33: 1164-1168. PMID: 10334805.
7. Campbell-Boswell, M., and Robertson, A.L. 1981. Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp. Mol. Pathol. 35: 265-266. doi: 10.1016/0014-4800(81) 90066-6. PMID: 7286164.
8. Cheon, K.T., Choi, K.H., Lee, H.B., Park, S.K., Rhee, Y.K., and Lee, Y.C. 2000. Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with lung cancer. Lung, 178: 351-360. doi: 10.1007/s004080000039. PMID: 11361058.
9. Chobanian, A.V., Haudenschild, C.C., Nickerson, C., and Hope, S. 1992. Trandolapril inhibits atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Hypertension, 20: 473-477. PMID: 1398882.
10. Craven, P.A., and DeRubertis, F.R. 1978. Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heme and hemeproteins. J. Biol. Chem. 253: 8433-8443. PMID: 30778.
11. Dzau, V.J. 1993. Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch. Intern. Med. 153: 937-942. doi: 10. 1001/archinte.153.8.937. PMID: 8386920.
12. Erdös, E.G. 1990. Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension, 16: 363-370. PMID: 2170273.
13. Erdös, E.G., and Skidgel, R.A. 1986. The unusual substrate specificity and the distribution of human angiotensin I converting enzyme. Hypertension, 8: 134-137.
14. Fatini, C., Gensini, F., Sticchi, E., Battaglini, B., Angotti, C., Conforti, M.L., et al. 2002. High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis. Am. J. Med. 112: 540-544. doi: 10.1016/80002-9343(02)01069-0. PMID: 12015245.
15. Furchgott, R.F., and Zawadski, J.V. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288: 373-376. doi: 10.1038/288373a0. PMID: 6253831.
16. Garg, U.C., and Hassid, A. 1989. Nitric oxide-generating vasodilators and 8-bromo cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83: 1774-1777. PMID: 2540223.
17. Higashi, Y., Oshima, T., Ono, N., Hiraga, H., Yoshimura, M., Watanabe, M., et al. 1995. Intravenous administration of L-arginine inhibits angiotensin-converting enzyme in humans. J. Clin. Endocrinol. Metab. 80: 2198-2202. doi: 10.1210/jc.80.7.2198. PMID: 7608279.
18. Hingorani, A.D. 2000. polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2000. Atherosclerosis, 154: 521-527. PMID: 11257252.
19. Ignarro, L.J., Buga, G.M., Wood, K.S., Byrns, R.E., and Chaudhuri, G. 1987. Endothelium derived relaxing factor produced and released from artery and vein is nitric oxide. proc. Natl. Acad. Sci. USA, 84: 9265-9269. PMID: 2827174.
20. Jacobsson, L.S., Persson, K., Aberg, G., Andersson, R.G.G., Karlberg, B.E., and Olsson, A.G. 1994. Anti-atherosclerotic effects of the angiotensin-converting enzyme inhibitors captopril and fosinopril in hypercholesterolemic mini pigs. J. Cardiovasc. pharmacol. 24: 670-677. PMID: 7528851.
21. Katz, R.J., Levy, W.S., Buff, L., and Wasserman, A.G. 1991. prevention of nitrate tolerance with angiotensin converting enzyme inhibitors. Circulation, 83: 1271-1277. PMID: 1901528.
22. Kurz, S., Hink, U., Nickenig, G., Borthayre, A.B., Harrison, D.G., and Münzel, T. 1999. Evidence for a casual role of the renin-angiotensin system in nitrate tolerance. Circulation, 99: 3181-3187. PMID: 10377083.
23. Nyström, F.H., Ahlner, J., Karlberg, B.E., and Öhman, P.K. 1998. A population-based study of plasma cyclic guanosine monophosphate: relations to age, atrial natriuretic factor and angiotensin-converting enzyme activity. Scand. J. Clin. Lab. Invest. 58: 605-610. PMID: 10088196.
24. Persson, K., and Andersson, R. G.G. 1999. Nitric oxide modulates captopril-mediated angiotensin-converting enzyme inhibition in porcine iliac arteries. Eur. J. Pharmacol. 385: 21-27. doi: 10. 1016/80014-2999(99)00689-5. PMID: 10594341.
25. persson, K., Whiss, p.A., Nyhlén, K., Jacobsson-Strier, M., Glindell, M., and Andersson, R.G.G. 2000. Nitric oxide donors and angiotensin-converting enzyme inhibitors act in concert to inhibit human angiotensin-converting enzyme activity and platelet aggregation in vitro. Eur. J. pharmacol. 406: 15-23. doi: 10. 1016/80014-2999(00)00647-6. PMID: 11011027.
26. Radomski, M.W., Palmer, R.M.J., and Moncada, S. 1987. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br. J. pharmacol. 92: 639-646. PMID: 3322462.
27. Rapoport, R.M., and Murad, F. 1983. Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMp. Circ. Res. 52: 352-357. PMID: 6297832.
28. Reid, I.A. 1985. The renin-angiotensin system and body function. Arch. Intern. Med. 145: 1475-1479. doi: 10.1001/archinte.145. 8.1475. PMID: 2992406.
29. Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., and Soubrier, F. 1990. An insertion/deletion polymorphism in the angiotensin I-converting enzyme enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86: 1343-1346. PMID: 1976655.
30. The MERCATOR study group. 1992. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study. Circulation, 86: 100-110. PMID: 1535568.
31. Wang, J.-G., and Staessen, J.A. 2000. Genetic polymorphism in the renin-angiotensin system: relevance for susceptibility to cardiovascular diseases. Eur. J. pharmacol. 410: 289-302. doi: 10. 1016/80014-2999(00)00822-0. PMID: 11134677.
32. Yan, C., Kim, D., Aizawa, T., and Berk, B.C. 2003. Functional interplay between angiotensin II and nitric oxide. Arterioscler. Thromb. Vasc. Biol. 23: 26-39. PMID: 12524221.